What do I need to know about immunoglobulin light chain (AL) amyloidosis? - ScienceDirect
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases - Garcia‐Pavia - 2021 - European Journal of Heart Failure -
AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy - ScienceDirect
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics | Nature Communications
Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management | JACC: CardioOncology
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis | Haematologica
Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment - Gertz - 2020 - American Journal of Hematology - Wiley Online Library